ST. PETERSBURG, FL -- (MARKET WIRE) -- 04/09/2007 -- Hathaway Corporation (PINKSHEETS: HWYI), a business development company that focuses on companies in the communications, telecommunications software and medical devices industries, announced the company has hired Mr. Reed Majors as President of their wholly owned subsidiary, Diabetes Detection, Inc.

Mr. Majors comes to DDI with over thirteen years experience in the Telecom industry at five companies, NUKO Information Systems, Optivision, Minerva Networks, Amdocs, and FutureDial. During his tenure at these companies he has been directly responsible for the product architecture, management, and marketing of numerous multi-million dollar product lines.

At FutureDial he was responsible for the marketing, product management, and business development for their market leading handset content management solution. Mr. Majors has a BS in Business Economics from the University of California, and an MBA from the Monterey Institute of International Studies.

DDI's patented early stage diabetes detection device will allow physicians to diagnose neuropathy and early stage diabetes by holding a Blackberry® against a patient's leg or other extremity to test for quantified sensation levels. This data can then be wirelessly sent to a clinical information system for further analysis.

"We’re excited to announce that Mr. Majors will be joining the management team of DDI. His experience in telecommunications, business strategy, and his extensive experience in launching new products and services will serve DDI well as we move to implement our products into the wireless field," stated Mr. Paul D. Lisenby, interim Chairman and CEO of Hathaway Global.

*Blackberry® is a registered trademark of RIM and is in no way associated with Hathaway Corporation and or its subsidiaries. The BlackBerry® and RIM families of related marks, images and symbols are the exclusive properties and trademarks of Research In Motion Limited.

About Hathaway

Hathaway Corporation is a business development company that focuses on acquiring companies in the telecommunications, software, and medical devices industries that bring a dynamic shift in how communications and information is delivered and serviced globally. Hathaway’s wholly owned subsidiaries; Opticon Systems, Inc. and Diabetes Detection, Inc. possess technologies that will have a dramatic impact in the business world now, and in the future. To request further information about Hathaway, please email us at investors@hathawayglobal.com

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.